Global market for antimicrobials of farm animals by 2026
In 2020, the segment of agricultural livestock accounted for 73.4%. This segment is expected to exhibit the highest average annual growth rate of 6.9%. A large share of this segment is mainly due to the growing demand for food of animal origin.
MARKETING AND SALES STRATEGY
Stemtrix medications will be produced as a radical reduction in the use of antibacterial drugs and antibiotics in the feeding, prevention and treatment of animals and poultry.
Sales model B2B
Markets are largely concentrated: 9 large producers account for more than 70% of all meat products in the USA, this situation is similar for other developed countries. In accordance with the business plan, Stemtrix is going to take 2-5% share of the animal antibiotic market in each region within four years after entering the market. Management understands the level of competition Stemtrix may face from antibiotic manufacturers.
Sales strategy
- Approval of drugs in the markets of Israel, EU, China, USA, Brazil, India and Mexico;
- Research and development of new drugs, new molecules and molecular solutions (GLP Laboratory Israel);
- Manufacturing of medicines and their components (EU GMP, India);
- Selling drugs and licenses for their production in the markets of Israel, the EU, China, USA, Brazil, India, Mexico.